Reference health
Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors
94/94 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 94 checked references that resolve
resolves10.1001/jamainternmed.2016.7507
Adult Utilization of Psychiatric Drugs and Differences by Sex, Age, and Race
resolves10.1002/pds.2082
Increasing off‐label use of antipsychotic medications in the United States, 1995–2008
resolves10.1016/j.tem.2014.07.004
Molecular pathophysiology of metabolic effects of antipsychotic medications
resolves10.3389/fnins.2017.00432
Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia
resolves10.1074/jbc.M505560200
Dopamine D2-like Receptors Are Expressed in Pancreatic Beta Cells and Mediate Inhibition of Insulin Secretion
resolves10.1210/me.2012-1101
Dopamine-Mediated Autocrine Inhibitory Circuit Regulating Human Insulin Secretion in Vitro
resolves10.1038/s41380-018-0344-6
New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion
resolves10.1371/journal.pone.0148684
Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence
resolves10.1210/me.2012-1226
Dopamine Synthesis and D3 Receptor Activation in Pancreatic β-Cells Regulates Insulin Secretion and Intracellular [Ca2+] Oscillations
resolves10.1210/en.2003-1099
Glucose Sensitivity and Metabolism-Secretion Coupling Studied during Two-Year Continuous Culture in INS-1E Insulinoma Cells
resolves10.1210/en.2009-0996
Disruption of the Dopamine D2 Receptor Impairs Insulin Secretion and Causes Glucose Intolerance
resolves10.1159/000114744
Effects of Long-Term L-Dopa Therapy on Carbohydrate Metabolism in Patients with Parkinson’s Disease
resolves10.1007/BF00745138
Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion
resolves10.1007/BF00251017
Effect of increased pancreatic islet norepinephrine, dopamine and serotonin concentration on insulin secretion in the Golden hamster
resolves10.1016/j.cmet.2012.10.019
Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin Production
resolves10.1016/j.amjmed.2007.08.036
Abnormalities in Glucose Metabolism in Patients with Schizophrenia Treated with Atypical Antipsychotic Medications
resolves10.1530/JOE-14-0614
Lack of glucagon receptor signaling and its implications beyond glucose homeostasis
resolves10.1007/s00125-008-1152-3
Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat
resolves10.1248/bpb.b18-00195
Clozapine-Induced Acute Hyperglycemia Is Accompanied with Elevated Serum Concentrations of Adrenaline and Glucagon in Rats
resolves10.1016/j.psyneuen.2017.05.005
Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia
resolves10.1007/s00441-014-1894-9
Distinctive expression and cellular distribution of dopamine receptors in the pancreatic islets of rats
resolves10.1097/MPA.0000000000000357
Pancreatic Endocrine Effects of Dopamine Receptors in Human Islet Cells
resolves10.2337/diab.28.10.899
Effect of Norepinephrine on Insulin, Glucagon, and Somatostatin Secretion in Isolated Perifused Rat Islets
resolves10.1016/j.cmet.2011.05.008
Innervation Patterns of Autonomic Axons in the Human Endocrine Pancreas
resolves10.1210/jcem-45-6-1154
Differential Effects of<scp>l</scp>-Dopa and Apomorphine on Glucagon Secretion in Man: Evidence Against Central Dopaminergic Stimulation of Glucagon
resolves10.1007/s00125-017-4409-x
Human pancreatic neuro-insular network in health and fatty infiltration
resolves10.1210/me.2013-1083
Minireview: Dopaminergic Regulation of Insulin Secretion from the Pancreatic Islet
resolves10.1210/jcem.82.11.4339
Substantial Production of Dopamine in the Human Gastrointestinal Tract
resolves10.1124/pr.56.3.1
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
resolves10.1159/000126394
Immunohistochemical Investigation of Tyrosine-Hydroxylase in the Islets of Langerhans of Adult Mice, Rats and Guinea Pigs
resolves10.1016/S0040-8166(96)80040-1
Immunocytochemical colocalizations of insulin, aromatic L-amino acid decarboxylase, dopamine beta-hydroxylase, S-100 protein and chromogranin A in B-cells of the chicken endocrine pancreas
resolves10.1001/archpsyc.59.4.337
Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia
resolves10.2337/db13-0430
Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease
resolves10.3791/57531
Homogeneous Time-resolved F&#246;rster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
resolves10.1046/j.1600-6143.2003.00184.x
Flexible Management of Enzymatic Digestion Improves Human Islet Isolation Outcome from Sub‐Optimal Donor Pancreata
resolves10.1007/s12035-018-1004-1
α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands
resolves10.1016/0006-2952(73)90196-2
Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
resolves10.1016/j.celrep.2018.02.032
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes
resolves10.1016/j.cmet.2018.10.007
Ectonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic β Cells for In Vitro and In Vivo Analysis
resolves10.1016/j.molmet.2016.04.007
Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets
resolves10.1093/nar/gkv007
limma powers differential expression analyses for RNA-sequencing and microarray studies
resolves10.1073/pnas.91.8.3242
Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells.
resolves10.1172/JCI107395
Adrenergic Receptors and the Secretion of Glucagon and Insulin from the Isolated, Perfused Canine Pancreas
resolves10.1530/eje.0.1490343
Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice
resolves10.1016/j.schres.2011.06.004
Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: An animal model
resolves10.1159/000321395
New Insights into the Endocrine and Metabolic Roles of Dopamine D2 Receptors Gained from the <i>Drd2</i><sup>–/–</sup> Mouse
resolves10.1016/j.semcdb.2012.09.007
Paracrine and autocrine interactions in the human islet: More than meets the eye
resolves10.1152/advan.00167.2012
Interactions between the central nervous system and pancreatic islet secretions: a historical perspective
resolves10.1073/pnas.0510790103
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function
resolves10.1074/jbc.RA117.001102
Islet proteomics reveals genetic variation in dopamine production resulting in altered insulin secretion
resolves10.1124/mol.61.4.729
Transport of Amino Acid-Related Compounds Mediated by L-Type Amino Acid Transporter 1 (LAT1): Insights Into the Mechanisms of Substrate Recognition
resolves10.1254/jphs.12124FP
Establishment of Stable Cell Lines With High Expression of Heterodimers of Human 4F2hc and Human Amino Acid Transporter LAT1 or LAT2 and Delineation of Their Differential Interaction With ^|^alpha;-Alkyl Moieties
resolves10.1124/jpet.114.216317
The Molecular Mechanism of Intestinal Levodopa Absorption and Its Possible Implications for the Treatment of Parkinson’s Disease
resolves10.1042/cs0920423
Effects of Ordinary Meals on Plasma Concentrations of 3,4-Dihydroxyphenylalanine, Dopamine Sulphate and 3,4-Dihydroxyphenylacetic Acid
resolves10.1152/ajpendo.2000.279.4.E815
DOPA, dopamine, and DOPAC concentrations in the rat gastrointestinal tract decrease during fasting
resolves10.1124/jpet.103.049270
Sources and Significance of Plasma Levels of Catechols and Their Metabolites in Humans
resolves10.1002/cne.901630406
The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine‐<i>B</i>‐hydroxylase as a marker
resolves10.1016/j.neures.2010.03.008
Binding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human α2-adrenergic and dopaminergic receptors
resolves10.1002/cne.21861
Interplay among catecholamine systems: Dopamine binds to α<sub>2</sub>‐adrenergic receptors in birds and mammals
resolves10.1016/j.jchemneu.2007.10.004
Dopamine binds to α2-adrenergic receptors in the song control system of zebra finches (Taeniopygia guttata)
resolves10.1159/000486241
Differential Response of Dopamine Mediated by β-Adrenergic Receptors in Human Keratinocytes and Macrophages: Potential Implication in Wound Healing
resolves10.1038/sj.bjp.0701574
Dopamine stimulation of cardiac <i>β</i>‐adrenoceptors: the involvement of sympathetic amine transporters and the effect of SKF38393
resolves10.1016/j.bmc.2016.04.028
Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists
resolves10.1124/mol.115.101808
Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist
resolves10.1038/s42003-018-0134-3
Conformational signatures in β-arrestin2 reveal natural biased agonism at a G-protein-coupled receptor
resolves10.1016/j.bbadis.2016.05.008
Biased signaling initiated by agouti-related peptide through human melanocortin-3 and -4 receptors
resolves10.1021/acschemneuro.9b00195
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses
resolves10.1124/pr.116.013367
The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling
resolves10.1101/gr.212720.116
Single-cell transcriptomes identify human islet cell signatures and reveal cell-type–specific expression changes in type 2 diabetes
resolves10.1016/j.pharmthera.2019.07.003
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas
resolves10.1172/JCI107823
Characterization of the Effects of Arginine and Glucose on Glucagon and Insulin Release from the Perfused Rat Pancreas
resolves10.3109/03009734.2016.1154905
Glucose control of glucagon secretion—‘There’s a brand-new gimmick every year’
resolves10.1530/JOE-14-0709
Inhibitory effect of somatostatin on insulin secretion is not mediated via the CNS
resolves10.1210/endo.141.1.7263
Somatostatin Inhibits Insulin and Glucagon Secretion via Two Receptor Subtypes: An in Vitro Study of Pancreatic Islets from Somatostatin Receptor 2 Knockout Mice*
resolves10.1038/s42255-019-0158-0
Somatostatin secretion by Na+-dependent Ca2+-induced Ca2+ release in pancreatic delta cells
resolves10.1007/s40263-020-00718-4
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
resolves10.2147/NDT.S113099
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence
The 7 references without a DOI — listed, not checked
no DOI — not checkedChaudhry, S., Bernardes, M., Harris, P. E. & Maffei, A. Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity. Miner. Endocrinol. 41, 43–56 (2016).
no DOI — not checkedPersson-Sjogren, S., Forsgren, S. & Taljedal, I. B. Tyrosine hydroxylase in mouse pancreatic islet cells, in situ and after syngeneic transplantation to kidney. Histol. Histopathol. 17, 113–121 (2002).
no DOI — not checkedBertera, S., Balamurugan, A. N., Bottino, R., He, J. & Trucco, M. Increased yield and improved transplantation outcome of mouse islets with bovine serum albumin. J. Transpl. 2012, 856386 (2012).
no DOI — not checkedEldrup, E., Richter, E. A. & Christensen, N. J. DOPA, norepinephrine, and dopamine in rat tissues: no effect of sympathectomy on muscle DOPA. Am. J. Physiol. 256, E284–E287 (1989).
no DOI — not checkedLindvall, O. & Bjorklund, A. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol. Scand. Suppl. 412, 1–48 (1974).
no DOI — not checkedGoldman-Rakic, P. S., Lidow, M. S., Smiley, J. F. & Williams, M. S. The anatomy of dopamine in monkey and human prefrontal cortex. J. Neural Transm. Suppl. 36, 163–177 (1992).
no DOI — not checkedZhang, W., Klimek, V., Farley, J. T., Zhu, M. Y. & Ordway, G. A. alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine. J. Pharm. Exp. Ther. 289, 1286–1292 (1999).
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1038/s41398-020-01171-z"><img src="https://citestamp.com/citestamped/10.1038/s41398-020-01171-z/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1038/s41398-020-01171-z)